Soy isoflavones prevent the ovarian hormone deficiency-associated rise in leukocytes in rats

Phytomedicine

Volumn 11, Issue 4, 2004, Pages 303-308

  Soung, D Y ^a   Khalil, D A ^a   Arquitt, A B ^a   Smith, B J ^a   Hammond, L J ^a   Droke, E A ^a   Lucas, E A ^a   Devareddy, L ^a   Arjmandi, B H ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Hematopoiesis; Ipriflavone; Lymphocytes; Lymphocytopenia

Indexed keywords

DAIDZIN; GENISTIN; GLYCITEIN; IPRIFLAVONE; ISOFLAVONE DERIVATIVE; NOVASOY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; EOSINOPHIL; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; HORMONE DEFICIENCY; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; LYMPHOPOIESIS; MONOCYTE; NONHUMAN; OVARIECTOMY; OVARY FUNCTION; POSTMENOPAUSE; PRIORITY JOURNAL; RAT; SOYBEAN; STATISTICAL SIGNIFICANCE;

ANIMALIA; GLYCINE MAX;

EID: 2442716133     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/0944711041495164     Document Type: Article

References (28)

1. Agnusdei D, Crepaldi G, Isaia G, Mazzuoli G, Ortolani S, Passeri M, Bufalino L, Gennari C (1997) A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss. Calcif Tissue Int 61: 142-147
2. Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY (2001) Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 285: 1482-1488
3. Arjmandi BH, Khalil DA, Hollis BW (2000) Ipriflavone, a synthetic phytoestrogen, enhances intestinal calcium transport in vitro. Calcif Tissue Int 67: 225-229
4. Arjmandi BH, Khalil DA, Hollis BW (2002) Soy Protein: Its Effects on Intestinal Calcium Transport, Serum Vitamin D, and Insulin-like Growth Factor-I in Ovariectomized Rats. Calcif Tissue Int 70: 483-487
5. Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, Wild RA (2003) Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 88: 1048-1054
6. Arjmandi BH, Smith BJ (2002) Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem 13: 130-137
7. Ben Hur H, Mor G, Insler V, Blickstein I, Amir-Zaltsman Y, Sharp A, Globerson A, Kohen F (1995) Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am J Reprod Immunol 34: 363-369
8. Blum A, Lang N, Vigder F, Israeli P, Gumanovsky M, Lupovitz S, Elgazi A, Peleg A, Ben Ami M (2003) Effects of soy protein on endothelium-dependent vasodilatation and lipid profile in postmenopausal women with mild hypercholesterolemia. Clin Invest Med 26: 20-26
9. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106: 1229-1237
10. Chiechi LM, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F, Valerio T, Laselva G, Loizzi P (2002) Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 42: 295-300
11. Erben RG, Raith S, Eberle J, Stangassinger M (1998) Ovariectomy augments B lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow. Am J Physiol 274: E476-E483
12. Erlandsson MC, Jonsson CA, Lindberg MK, Ohlsson C, Carlsten H (2002) Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice. J Endocrinol 175: 319-327
13. Giglio T, Imro MA, Filaci G, Scudeletti M, Puppo F, De Cecco L, Indiveri F, Costantini S (1994) Immune cell circulating subsets are affected by gonadal function. Life Sci 54:1305-1312
14. Ishimi Y, Miyaura C, Ohmura M, Onoe Y, Sato T, Uchiyama Y, Ito M, Wang X, Suda T, Ikegami S (1999) Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140: 1893-1900
15. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL (2002) Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25: 1709-1714
16. Jilka RL, Passeri G, Girasole G, Cooper S, Abrams J, Broxmeyer H, Manolagas SC (1995) Estrogen loss upregulates hematopoiesis in the mouse: a mediating role of IL-6. Exp Hematol 23: 500-506
17. Kalu DN, Salerno E, Liu CC, Ferarro F, Arjmandi BH, Salih MA (1993) Ovariectomy-induced bone loss and the hematopoietic system. Bone Miner 23: 145-161
18. Kamada M, Irahara M, Maegawa M, Yasui T, Takeji T, Yamada M, Tezuka M, Kasai Y, Aono T (2000) Effect of hormone replacement therapy on post-menopausal changes of lymphocytes and T cell subsets. J Endocrinol Invest 23: 376-382
19. Kamada M, Irahara M, Maegawa M, Yasui T, Yamano S, Yamada M, Tezuka M, Kasai Y, Deguchi K, Ohmoto Y, Aono T (2001) B cell subsets in postmenopausal women and the effect of hormone replacement therapy. Maturitas 37: 173-179
20. Mahavni V, Sood AK (2001) Hormone replacement therapy and cancer risk. Curr Opin Oncol 13: 384-389
21. Masuzawa T, Miyaura C, Onoe Y, Kusano K, Ohta H, Nozawa S, Suda T (1994) Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 94: 1090-1097
22. McDonnell DP, Connor CE, Wijayaratne A, Chang CY, Norris JD (2002) Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog Horm Res 57: 295-316
23. Medina KL, Strasser A, Kincade PW (2000) Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95: 2059-2067
24. Onoe Y, Miyaura C, Ito M, Ohta H, Nozawa S, Suda T (2000) Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res 15: 541-549
25. Scheiber MD, Liu JH, Subbiah MT, Rebar RW, Setchell KD (2001) Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 8: 384-392
26. Setchell KD (2001) Soy isoflavones - benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 20: 354S-362S
27. Watanabe S, Uesugi S, Kikuchi Y (2002) Isoflavones for prevention of cancer, cardiovascular diseases, gynecological problems and possible immune potentiation. Biomed Pharmacother 56: 302-312
28. Yamori Y, Moriguchi EH, Teramoto T, Miura A, Fukui Y, Honda KI, Fukui M, Nara Y, Taira K, Moriguchi Y (2002) Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil: a ten-week study. J Am Coll Nutr 21: 560-563